Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

NCT04835883 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)

Sponsor

Hanyang University Seoul Hospital

Collaborators

[object Object]
[object Object]